Reply to: ‘IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma’

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

(2019) Alexander C. Huang et al.   NATURE MEDICINE

IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma

(2019) Jason A. Carter et al.   NATURE MEDICINE

Limitations of alignment-free tools in total RNA-seq quantification

(2018) Douglas C. Wu et al.   BMC GENOMICS

Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma

(2018) Noam Auslander et al.   NATURE MEDICINE

The late acceptance Hill-Climbing heuristic

(2017) Edmund K. Burke et al.   EUROPEAN JOURNAL OF OPERATIONAL RESEARCH

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

(2015) E. M. Van Allen et al.   SCIENCE

Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples

(2012) Günter P. Wagner et al.   THEORY IN BIOSCIENCES

GlobalMIT: learning globally optimal dynamic bayesian network with the mutual information test criterion

(2011) N. X. Vinh et al.   BIOINFORMATICS